Real-world impact of fremanezumab on migraine-related health care utilization and costs in patients with common comorbidities, acute medication overuse, or difficult-to-treat migraine
D. C. Buse,M. T. Driessen,L. J. Krasenbaum,M. J. Seminerio,K. Carr,M. Ortega,E. R. Packnett
